Examples of 'fingolimod' in a sentence
Meaning of "fingolimod"
Fingolimod is an adjective used to describe a drug that helps in treating multiple sclerosis by regulating the immune system
Show more definitions
- An immunosuppressive drug 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol
How to use "fingolimod" in a sentence
Basic
Advanced
fingolimod
Fingolimod hydrochloride exists in a stable crystalline form.
Gilenya contains the active substance fingolimod.
Fingolimod can induce bradycardia upon treatment initiation.
Pharmacokinetic interactions of other substances on fingolimod.
Fingolimod was excreted in milk of treated animals during lactation.
Caution is therefore indicated when stopping fingolimod therapy.
Fingolimod was neither mutagenic nor clastogenic in animal studies.
The present disclosure provides an amorphous fingolimod hydrochloride.
Fingolimod has been studied in combination with atenolol and diltiazem.
Gilenya is a medicine that contains the active substance fingolimod.
Fingolimod treatment is not associated with a decrease in cardiac output.
The active substance is fingolimod.
Fingolimod and teriflunomide are taken through a daily single dose.
There are no data on the effects of fingolimod on labour and delivery.
Fingolimod is a novel compound produced by chemical modification of a fungal precursor.
See also
Thermophilic fungi were the source of the fingolimod precursor myriocin.
The solution of fingolimod hydrochloride is fed into a spray drier.
Intermediate compounds and process for the preparation of fingolimod.
Fingolimod is metabolised by sphingosine kinase to the active metabolite fingolimod phosphate.
The pharmacologically active metabolite responsible for efficacy is fingolimod phosphate.
Fingolimod is an immunosuppressant and immunosuppression conditions are risk factors for dysimmunity.
Monocytes are unaffected by fingolimod.
Dosage regimen for fingolimod for the treatment of multiple sclerosis.
Potent inhibitors of transporter proteins are not expected to influence fingolimod disposition.
Fingolimod and its metabolites crossed the placental barrier in pregnant rabbits.
Natalizumab and fingolimod.
The solution of fingolimod hydrochloride is fed into a rotavapor and the solvent is removed.
We further studied their modulation by ivMP and by treatment with fingolimod.
Required prior to treatment with fingolimod and alemtuzumab in patients without previous exposure.
Do not use this medication if you are already using immunosuppressives such as fingolimod.
The reaction of fingolimod with hydrochloric acid may be carried out in an alcoholic solvent.
There are very limited data from the use of fingolimod in pregnant women.
Concomitant use of fingolimod with beta blockers may potentiate bradycardic effects and is not recommended.
The reaction mixture obtained may be cooled to obtain crystalline fingolimod hydrochloride.
These measures must be implemented before fingolimod is prescribed to female patients and during treatment.
Neither dialysis nor plasma exchange results in removal of fingolimod from the body.
This research suggests that fingolimod may be helpful for treating mucolipidosis IV.
Starting other therapies during this interval will result in concomitant exposure to fingolimod.
The present disclosure provides a process for preparing fingolimod hydrochloride by reacting fingolimod with hydrochloric acid.
Depression and anxiety have also been reported in paediatric patients treated with fingolimod.
EMA recommends restrictions for fingolimod use in women.
Starting AUBAGIO during this interval will result in concomitant exposure to fingolimod.
TECFIDERA demonstrated comparable effectiveness to fingolimod and was less effective than natalizumab and alemtuzumab.
The exact frequency of rare side effects such as severe infections of fingolimod is unknown.
Fingolimod is a daily MS pill being developed by Novartis.
The active substance of Gilenya is fingolimod.
Response to Fingolimod can be predicted.
There are also anecdotal reports against using Fingolimod.
You are either on Fingolimod or Avonex.
What Gilenya is The active substance of Gilenya is fingolimod.
